1- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global Cancer Statistics, 2012.CA: A Cancer Journal for Clinicians 65 (2): 87-108.
2- Galukande M, Wabinga H, Mirembe F, Karamagi C, Asea A (2014) Molecular breast cancer subtypes prevalence in an indigenous Sub-Saharan African population. Pan African Med J 17: 249.
3- Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J, et al (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Research 20(2):170-9.
4- Wilting RH, Dannenberg JH (2012) Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance. Drug Resist Update Feb-Apr;15(1-2):21-38. doi: 10.1016/j.drup.2012.01.008. Epub 2012 Feb 20. PMID: 22356866.
5- Glusman G, Yanai I, Rubin I, Lancet D (2001) The complete human olfactory subgenome.Genome Res 11: 685–702.
6- Verbeurgt C, Wilkin F, Tarabichi M, Gregoire F, Dumont JE, ChatelainP (2014) Profiling of Olfactory Receptor Gene Expression in Whole Human Olfactory Mucosa. PLoS ONE 9 (5): e96333.
7- Ignatieva EV, Levitsky VG, Yudin NS, Moshkin MP, Kolchanov NA (2014) Genetic basis of olfactory cognition: extremely high level of DNA sequence polymorphism in promoter regions of the human olfactory receptor genes revealed using the 1000 Genomes Project dataset. Front. Psychol 5: 247.
8- Mainland JD, Keller A, Li YR, Zhou T, Trimmer C, Snyder LL, et al (2014) The missense of smell: functional variability in the human odorant receptor repertoire. Nat sNeurosci 17: 114–20.
9- Feldmesser E, Olender T, Khen M, Yanai I, Ophir R, Lancet D (2006) Widespread ectopic expression of olfactory receptor genes. BMC Genomics 7:121.
10- Kang N, Koo J (2012) Olfactory receptors in non-chemosensory tissues. BMB Reports 45(11):612-22.
11- Zhang X, Bedigian AV, Wang W, Eggert US (2012) G-protein-coupled receptors participate in cytokinesis. Cytoskeleton Hoboken, N.J 69(10): 810–8.
12- Zhao W, Ho L, Varghese M, et al (2013) Decreased level of olfactory receptors in blood cells following traumatic brain injury and potential association with tauopathy. J Alzheimers Dis 34: 417–29
13- Flegel C, Manteniotis S, Osthold S, Hatt H, Gisselmann G (2013) Expression profile of Ectopic Olfactory Receptors Determined by Deep Sequencing. PLoSOne 8(2) : e55368.
14- Fukuda, N, Touhara K (2006) Developmental expression patterns of testicular olfactory receptor genes during mouse spermatogenesis.Genes Cells 11: 71–81.
15- Griffin CA, Kafadar KA, Pavlath GK (2009) MOR23 promotes muscle regeneration and regulates cell adhesion and migration. Developmental cell 17(5):649-661.
16- Dreyer WJ (1998) The area code hypothesis revisited: Olfactory receptors and other related transmembrane receptors may function as the last digits in a cell surface code for assembling embryos. Proceedings of the National Academy of Sciences of the United States of America 95(16): 9072–7.
17- Liu Y, Pike MC, Wu N, Lin YG, Mucowski S, Punj V, et al (2015) BRCA1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived Scent. PLoS ONE 10(10): e0139013.
18- Dorsam RT, Gutkind JS (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7:79–94.
19- Sanz G, Leray I, Dewaele A, Sobilo J, Lerondel S, Bouet S, Mir LM (2014) Promotion of Cancer Cell Invasiveness and Metastasis Emergence Caused by Olfactory Receptor Stimulation. PLoSONE 9 (1): e85110.
20- Muranen TA, Greco D, Fagerholm R, Kilpivaara O, Kämpjärvi K, Aittomäki K, Nevanlinna H (2011) Breast tumors from CHEK2 1100delC-mutation carriers: Genomic landscape and clinical implications. Breast Cancer Research 13 (5): R90.
21- Yahia ZA, Adam AA, Elgizouli M, Hussein A, Masri MA, Kamal M, Mohamed HS, Alzaki K, Elhassan AM, Hamad K, Ibrahim ME (2013 )Epstein Barr virus: a prime candidate of breast cancer aetiology in Sudanese patients. Cancer Infectious Agents Oct 9;13:469
22- Suleiman SH, Koko ME, Nasir WH, Elfateh O, Elgizouli UK, Abdallah MOE, et al (2015) Exome sequencing of a colorectal cancer family reveals shared mutation pattern and predisposition circuitry along tumor pathways. Front. Genet 6: 288.
23-Abdallah MOE1, Algizouli UK, Suliman MA, Abdulrahman RA, Koko M, Fessahaye G, Shakir JH, Fahal AH, Elhassan AM, Ibrahim ME, Mohamed HS, EBV Associated Breast Cancer Whole Methylome Analysis Reveals Viral and Developmental Enriched Pathways.FrontOncol. 2018 Aug 13;8:316.
24- Gupta N, Singh PP, Goyal A, Bhatia D (2013) Assessment of Olfaction Using the “I-Smell” Test in an Indian Population: A Pilot Study. Indian Journal of Otolaryngology and Head and Neck Surgery 65(1):6-11
25- Davidson TM, Freed C, Healy MP, Murphy C (1998) Rapid clinical evaluation of anosmia in children: the Alcohol Sniff Test. Ann N Y AcadSci 855:787-92
26- Harel A, Inger A, Stelzer G, Strichman-Almashanu L, Dalah I, Safran M, Lancet D (2009) GIFtS: annotation landscape analysis with GeneCards. BMC Bioinformatics 10 (1): 348.
27- Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC (1993) BCL-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.Blood 82:1820–28.
28- Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA et al (2003) Frequent hypomethylation of multiple genes over expressed in pancreatic ductal adenocarcinoma. Cancer Res 63: 4158–66.
29- Pulukuri SM, Estes N, Patel J, Rao JS (2007) Demethylation –linked activation of urokinase plasminogen activator is involved in progression of prostate cancer. Cancer Res 67:930-9.
30- Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z (2008) DNA hypomethylation arises later in prostate cancer progression than CpGslandhypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res 68(21): 8954-67.
31- Widschwendter M, Jiang G, Woods C, Muller HM, Fiegl H, Goebel, et al (2004) DNA hypomethylation and ovarian cancer biology. Cancer Res 64: 4472–80.
32- Pattamadilok J, Huapai N, Rattanatanyong P, et al (2008) LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer. Int J Gynecol Cancer 18:711–7.
33- Buck LB. (1992)The olfactory multigene-family. CurrOpinNeurobiol 2: 282– 288
34- Lappano R, Maggiolini M. G (2011) protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug DiscoV 10:47–60.
35- Brenet F, Moh M, Funk P, Feierstein E, Viale AJ, Socci ND, et al. (2011) DNA Methylation of the First Exon Is Tightly Linked to Transcriptional Silencing. PLoS ONE 6(1): e14524.
36- Malnic B, Godfrey PA, Buck LB (2004) The human olfactory receptor gene family. Proc Natl AcadSci USA 101 (8): 2584–9.
37- Newsham IF (1998) The Long and Short of Chromosome 11 in Breast Cancer.The American Journal of Pathology 153(1): 5–9.
38- Morissette G, Flamand L (2010) Herpesviruses and chromosomal integration. Journal of Virology 84: 12100–9.
39- Christiansen H, Lampert F (1988) Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 57:121-6.
40- Sreekantaiah C, Bhargava MK, Shetty NJ (1988) Chromosome 1 abnormalities in cervical carcinoma.Cancer 62: 1317–24.
41- Couturier-Turpin MH, Esnous C, Louvel A, Poirier Y, Couturier D (1992) Chromosome 1 in human colorectal tumors. Hum Genet 88: 431–8.
42- Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, RougéC,Theillet C (2006) Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. British Journal of Cancer 95(10): 1439–47.
43-Chen L C, Dollbaum C, Smith H S [1989] Loss of heterozygosity on chromosome 1q in human breast cancer. Proc. Nat. Acad. Sci. 86: 7204-7207.
44- Bieri S, Monastyrskaia K, Schilling B ( 2004) Olfactory receptor neuron profiling using Sandalwood odorants. Chem Senses 29 (6): 483–7.
45- Pick H, Etter S, Baud O, Schmauder R, Bordoli L, Schwede T, Vogel, H (2009) Dual Activities of Odorants on Olfactory and Nuclear Hormone Receptors. The Journal of Biological Chemistry 284(44): 30547–55.
46- Xu LL, Sun C, Petrovics G, Makarem M, Furusato B, Zhang W, et al (2006) Quantitative expression profile of PSGR in prostate cancer ”Prostate Cancer and Prostatic Diseases 9: 56–61.
47- Weng J, Wang J, Hu X, Wang F, Ittmann M, Liu M (2006) PSGR2, a novel G protein coupled receptor, is over expressed in human prostate cancer. Int J Cancer 118: 1471–80.
48- Neuhaus EM, Zhang W, Gelis L, Deng Y, Noldus J, Hatt H (2009) Activation of an Olfactory Receptor Inhibits Proliferation of Prostate Cancer Cells. The Journal of Biological Chemistry.; 284 (24): 16218–25.
49- Cao W, Li F, Yao J, Yu, J. (2015)Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion. BMC Cancer15: 915.
50- Keller A, Zhuang H, Chi Q, Vosshall L, Matsunami H (2007) Genetic variation in a human odorant receptor alters odour perception. Nature 449: 468–72.
51-Leja J, Essaghir A, Essand M, Wester K, Oberg K, Totterman TH et al. Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas. Mod Pathol. 2009; 22: 261–72.
52- Busse D, Kudella P, Grüning NM, Gisselmann G, Ständer S, Luger T, et al (2014)A synthetic sandalwood odorant induces wound healing processes in human keratinocytes via the olfactory receptor OR2AT4. J Invest Dermato 134: 2677–9.
53- Kuczewski N1, Fourcaud-Trocmé N2, Savigner A2, Thevenet M2, Aimé P2, Garcia S2, Duchamp-Viret P2, Palouzier-Paulignan B2 (2014) Insulin modulates network activity in olfactory bulb slices: impact on odour processing. J Physiol. 1;592(13):2751-69.